Mectizan Donation Program | Local power. Global Change.
MERCK A program at The Task Force for Global Health
Switch to French site

Celebrating 30 years of Merck & Co., Inc., Kenilworth, N.J., U.S.A.‘s* donation of Mectizan in 2017, “as much as needed, for as long as needed,” the Mectizan Donation Program is the longest-running Neglected Tropical Disease drug donation program. More than 300 million treatments of Mectizan and albendazole (donated by GSK) are provided yearly for river blindness (onchocerciasis) and lymphatic filariasis elimination worldwide.

*Merck & Co., Inc., Kenilworth, N.J., U.S.A., is known as MSD outside of the United States and Canada.

News, videos & resources

Get the latest on the Mectizan Donation Program

MDP Newsletter

Mectizan Program Notes: Summer 2018

Click the image to view the Summer 2018 Mectizan Program Notes:

 

 

MEC Guidelines and Recommendations

MEC Guide for Donations of Mectizan in IDA Countries

Guide for Donations of Mectizan® to Accelerate the Elimination of Lymphatic Filariasis in Countries where Onchocerciasis is not co-endemic.

Guide for Donations of Mectizan Application for IDA countries (949.30 KB)

Resources and Tools

Managing Morbidity and Preventing Disability (MMDP) Toolkit

The World Health Organization (WHO) is developing a toolkit to help programs implement MMDP services. The toolkit incorporates relevant resources developed by WHO and partner institutions, and its objectives are as follows:

provide tools and templates for implementation of key activities to strengthen delivery by the health system of the recommended minimum package of care for LF patients make information and tools accessible to national LF programs and health professionals around the world identify and resolve gaps in resources

Components focus on the following areas:

Planning, including patient estimation Capacity Building to Deliver MMDP Services Documentation of MMDP services
view more news & resources